Home Blog Page 687

MEXC Doubles Market Share to 9% in Two Years, CoinGecko Reports

By
Advertorial Desk
-

VICTORIA, Seychelles, April 13, 2026 /PRNewswire/ — CoinGecko has released its Spot CEX Report 2026, offering a comprehensive analysis of 12 leading centralized exchanges across multiple dimensions, including spot trading volume, market share trends, token listings, and reserve holdings. The report highlights that MEXC, the world leader in 0‑fee digital asset trading, increased its spot market share from 5% to 9% over the past two years—nearly doubling its position. Concurrently, MEXC ranked first among all major exchanges with 1,333 new token listings over the past year, demonstrating formidable competitive advantages in both asset coverage and trading activity.

MEXC Doubles Market Share to 9% in Two Years, CoinGecko Reports
MEXC Doubles Market Share to 9% in Two Years, CoinGecko Reports

Market Share Doubles as Trading Volume Remains Among Top Leaders

According to CoinGecko data, MEXC’s market share surged from 5% at the beginning of 2024 to 9% in 2026, firmly cementing the platform’s status among the world’s leading exchanges. Furthermore, MEXC recorded $95.9 billion in spot trading volume in February 2026, officially securing its position as the second-largest exchange globally in this category.

Leading the Industry in Asset Discovery and New Token Listings

Outpacing major competitors, MEXC ranks first in new token listings among the 12 centralized exchanges covered in the report. Since January 2025, the exchange has listed 1,333 new spot tokens, sustaining an onboarding rate of approximately 100 new assets per month.

To contextualize this scale, CoinGecko tracked 7,847 newly launched tokens across the broader market during this period. By listing approximately 17% of all newly created tokens, MEXC’s listing velocity aggressively outperforms the industry baseline, where most major competitors capture less than 5%. This performance demonstrates the operational superiority of MEXC’s listing infrastructure. The platform remains structurally engineered to offer the broadest asset coverage, ensuring users can capitalize on early-stage projects ahead of the wider market.

0 Fees Combined With Broad Asset Selection Drive Continued User Growth

Among the 12 centralized exchanges analyzed, MEXC maintains the industry’s lowest baseline trading costs, enforcing a 0.00% maker fee and a 0.10% taker fee. By contrast, competing major platforms mandate baseline fees of 0.10% or higher, with some exacting up to 0.50%.

MEXC’s 0-fee strategy has become a core driver of its sustained trading volume growth, helping millions of users worldwide save significantly on trading costs. Combined with 2,350 listed assets, this fee advantage has made MEXC a preferred platform for traders seeking both cost efficiency and broad asset diversity.

274.6% Reserve Expansion and 101M USDT Guardian Fund Anchor Platform Security

The CoinGecko report also highlights substantial changes in exchange reserves. Between January 2024 and February 2026, MEXC’s reserve value grew by 274.6%, reflecting accelerated institutional and retail capital inflows. Supporting this scale is the MEXC Guardian Fund, deployed in June 2025. Capitalized with over 100 million USDT, the fund establishes a structural defense against cybersecurity threats and technical disruptions.

Executing the Next Era of Global Leadership As MEXC reaches its eight-year milestone, the metrics confirmed by CoinGecko validate the exchange’s market dominance. Rather than resting on legacy achievements, MEXC is actively deploying its resources to upgrade its core trading engine, maintain its zero-fee advantage, and expand its global market share in the upcoming growth cycle.

About MEXC

MEXC is the world’s fastest-growing cryptocurrency exchange, trusted by more than 40 million users across 170+ markets. Built on a user-first philosophy, MEXC offers industry-leading 0-fee trading and access to over 3,000 digital assets. As the Gateway to Infinite Opportunities, MEXC provides a single platform where users can easily trade cryptocurrencies alongside tokenized assets, including stocks, ETFs, commodities, and precious metals.

MEXC Official Website｜ X ｜ Telegram ｜How to Sign Up on MEXC

China Automotive Systems to Announce Unaudited 2025 Fourth Quarter and Audited 2025 Year Financial Results on April 22, 2026

By
Advertorial Desk
-

WUHAN, China, April 13, 2026 /PRNewswire/ — China Automotive Systems, Inc. (Nasdaq: CAAS) (“CAAS” or the “Company”), a leading power steering components and systems supplier in China, today announced that it will issue unaudited financial results for the fourth quarter and audited financial results for the 2025 year ended December 31, 2025, on Wednesday, April 22, 2026, before the market opens.  Management will conduct a conference call on April 22nd at 8:00 A.M. EDT/8:00 P.M. Beijing Time to discuss these results.  A question and answer session will follow management’s presentation.

To participate, please call the following numbers 10 minutes before the call start time and ask to be connected to the “China Automotive Systems” conference call with pin 861648:

Toll Free: 888-506-0062

International: 973-528-0011

China Toll Free: 86 400 120 3199

A replay of the call will be available on the Company’s website in the investor relations section.

About China Automotive Systems, Inc. 

Based in Hubei Province, the People’s Republic of China, China Automotive Systems, Inc. is a leading supplier of power steering components and systems to the Chinese automotive industry, operating through its sixteen Sino-foreign joint ventures and wholly owned subsidiaries. The Company offers a full range of steering system parts for passenger automobiles and commercial vehicles. The Company currently offers four separate series of power steering with an annual production capacity of over 8 million sets of steering gears, columns and steering hoses. Its customer base is comprised of leading auto manufacturers, such as China FAW Group, Corp., Dongfeng Auto Group Co., Ltd., BYD Auto Company Limited, Beiqi Foton Motor Co., Ltd. and Chery Automobile Co., Ltd. in China, and Stellantis N.V. and Ford Motor Company in North America.  For more information, please visit: http://www.caasauto.com.

Forward-Looking Statements

This press release contains statements that are “forward-looking statements” as defined under the Private Securities Litigation Reform Act of 1995. Forward-looking statements represent our estimates and assumptions only as of the date of this press release. Our actual results may differ materially from the results described in or anticipated by our forward-looking statements due to certain risks and uncertainties. As a result, the Company’s actual results could differ materially from those contained in these forward-looking statements due to a number of factors, including those described under the heading “Risk Factors” in the Company’s Annual Report on Form 10-K as filed with the Securities and Exchange Commission on March 28, 2024, and in documents subsequently filed by the Company from time to time with the Securities and Exchange Commission. Any of these factors and other factors beyond our control, could have an adverse effect on the overall business environment, cause uncertainties in the regions where we conduct business, cause our business to suffer in ways that we cannot predict, and materially and adversely impact our business, financial condition and results of operations. A prolonged disruption or any further unforeseen delay in our operations of the manufacturing, delivery and assembly process within any of our production facilities could continue to result in delays in the shipment of products to our customers, increased costs and reduced revenue. We expressly disclaim any duty to provide updates to any forward-looking statements made in this press release, whether as a result of new information, future events or otherwise.

For further information, please contact:

Jie Li
Chief Financial Officer
China Automotive Systems, Inc.
jieli@chl.com.cn

Kevin Theiss
Awaken Advisors
+1-212-521-4050
Kevin@awakenlab.com

HKEX Advances Index Ecosystem with Two Tech-Focused Benchmarks

By
Advertorial Desk
-
  • HKEX launches the HKEX KRX Semiconductor Index and the HKEX Tech & US Tech 100 Index
  • These mark the latest development in HKEX’s index strategy, expanding its proprietary and co‑branded benchmark offerings
  • HKEX enters licensing agreements with 5 issuers to develop ETFs in Hong Kong tracking the two new benchmarks

HONG KONG, April 13, 2026 /PRNewswire/ — Hong Kong Exchanges and Clearing Limited (HKEX) is pleased to announce today (Monday) the expansion of its index portfolio with the introduction of two technology‑focused benchmarks: the HKEX KRX Semiconductor Index and the HKEX Tech & US Tech 100 Index.

As the first co‑branded index between HKEX and Korea Exchange (KRX), the HKEX KRX Semiconductor Index provides cross‑market exposure to Hong Kong‑listed semiconductor companies eligible for Southbound Stock Connect and to leading South Korean semiconductor names, represented by constituents of the KRX Semiconductor Top 15 Index.

The HKEX Tech & US Tech 100 Index tracks the performance of all constituents of the HKEX Tech 100 Index and the 100 largest Nasdaq‑listed technology companies by market capitalisation, including the Magnificent Seven.

With weightings of approximately 60 per cent for Stock Connect-eligible Hong Kong-listed companies and 40 per cent in overseas-listed companies, the indices are designed to support the development of exchange traded funds (ETFs) and to be eligible for inclusion under Southbound ETF Connect — enabling investors in the Chinese Mainland to access more diversified cross-market exposure.

HKEX is also pleased to announce it has entered into licensing agreements with Bosera Asset Management (International), Da Cheng International Asset Management, E Fund Management (Hong Kong), GF International Investment Management, and Huatai-PCG Asset Management, for the introduction of ETFs based on the two newly-launched indices in Hong Kong, subject to regulatory approval.

HKEX Chief Executive Officer, Bonnie Y Chan, said: “We are delighted to announce the launch of these exciting additions to HKEX’s index suite, part of our strategic commitment to building an exchange‑led index ecosystem that supports product innovation and market development. By expanding our proprietary and co‑branded benchmark offering, along with its strong focus on technology opportunities, we aim to create a liquidity flywheel—broadening the universe for index‑linked products, deepening market participation and enhancing vibrancy across both the primary and secondary markets.”

“We also warmly welcome the licensing agreements with Bosera International, Da Cheng International, E Fund HK, GF International, and Huatai-PCG to launch ETFs based on these new indices, underscoring our deep collaboration with the industry and our focus on developing indices that are fit for purpose, meeting the needs of our regional and international investors,” Ms Chan added.

As Hong Kong welcomes even more technology companies across different industries to list on its vibrant markets, investor demand for related products is becoming increasingly diverse. These new benchmarks are designed to reflect that evolution, offering targeted and diversified exposure to global and regional technology themes, whilst supporting the development of products tailored to different investment strategies and risk appetites.

Index methodology and additional information about the HKEX KRX Semiconductor Index and the HKEX Tech & US Tech 100 Index are available on the HKEX website.

HKEX Group Chief Information Officer Richard Leung (middle), HKEX Head of Markets Gregory Yu (second left), and HKEX Head of Data Business Winnie Sin (first left) met with KRX Director General of Index Business Kil Hyun Ahn (second right) and KRX Head of Index Business John Donghoon Shin (first right) at HKEX Connect Hall.
HKEX Group Chief Information Officer Richard Leung (middle), HKEX Head of Markets Gregory Yu (second left), and HKEX Head of Data Business Winnie Sin (first left) met with KRX Director General of Index Business Kil Hyun Ahn (second right) and KRX Head of Index Business John Donghoon Shin (first right) at HKEX Connect Hall.

About HKEX

Hong Kong Exchanges and Clearing Limited (HKEX) is a publicly-traded company (HKEX Stock Code: 388) and one of the world’s leading global exchange groups, offering a range of equity, derivative, commodity, fixed income and other financial markets, products and services, including the London Metal Exchange.

As a superconnector and gateway between East and West, HKEX facilitates the two-way flow of capital, ideas and dialogue between China and the rest of the world, through its pioneering Connect schemes, increasingly diversified product ecosystem and its deep, liquid and international markets.

HKEX is a purpose-led organisation which, across its business and through the work of HKEX Foundation, seeks to connect, promote and progress its markets and the communities it supports for the prosperity of all.

www.hkexgroup.com

Noah Medical Launches Deep-Dive Research Series on Medical Robotics Value

By
Advertorial Desk
-

Why the World’s Leading Medical Robotics Companies Put Clinical Value First

This article serves as a foundational study for the Noah Medical deep-dive series, aiming to help investors establish a core framework for assessing value in the medical robotics industry.

HONG KONG, April 13, 2026 /PRNewswire/ — Noah Medical has released the first article in its deep-dive research series on medical robotics, highlighting a major industry shift toward early-stage diagnosis and unveiling new clinical data from its Galaxy robotic bronchoscopy system, which has now been used in over 10,000 procedures globally.

As the medical robotics sector continues to gain momentum, market discussion tends to center on technical specifications and commercialization progress. Yet from a long-term investment perspective, these dimensions alone cannot explain the divergence in value among companies. What truly determines a medical robotics company’s long-term worth is not the technology itself—but the level of clinical problem it solves.

The global medical robotics market is projected to grow from roughly USD 70–80 billion in 2023 to over USD 200 billion by around 2030, representing a compound annual growth rate above 15%. More notable, however, is the structural shift underway: the industry’s core growth driver is moving rapidly from the “surgical execution end” toward the “diagnostic gateway”—that is, earlier disease detection and more accurate early-stage diagnosis and intervention. Competition around device performance is giving way to competition around solving clinical problems themselves.

I. A Three-Tier Value Framework: Problem Level Determines Long-Term Upside

At its core, medical innovation addresses clinical problems that can be organized into three progressive tiers:

  • Tier 1: Can it be done at all? — Procedures that were previously infeasible or unreliable, representing breakthroughs in clinical capability.
  • Tier 2: Can it be done faster? — Corresponding to efficiency gains.
  • Tier 3: Can it be done more affordably? — Corresponding to cost optimization.

Most medical robotics innovation today remains concentrated in the latter two tiers—essentially extending existing clinical capabilities. The truly scarce and defensible direction is Tier 1: using technology to make previously unachievable medical procedures safe and accurate, thereby creating breakthrough clinical value.

This logic has been validated repeatedly. The da Vinci Surgical System, with a global installed base exceeding 8,000 units and over 2 million annual procedures, owes its sustained high gross margins and steady growth to one thing: its irreplaceable ability to enable complex minimally invasive surgeries that could not otherwise be performed. The same principle applies to TAVR and electrophysiology ablation—each opened new markets by establishing entirely new clinical capabilities.

Companies that solve “can it be done at all” typically enjoy higher technological barriers, stronger pricing power, longer product lifecycles, and more pronounced valuation premiums.

II. An Overlooked Capability Gap: From Detection to Diagnosis

This framework is particularly clear in lung cancer care. Lung cancer remains one of the most prevalent and lethal malignancies worldwide, with over 2.2 million new cases and nearly 1.8 million deaths annually—accounting for more than 18% of all cancer-related mortality.

In recent years, the widespread adoption of low-dose CT screening (LDCT) has dramatically improved our ability to detect problems, with pulmonary nodule detection rates reaching 20–30% among high-risk populations. Diagnostic capability, however, has not kept pace—and has instead become a new systemic bottleneck.

Consider the challenge of peripheral lung nodules: over 65% of pulmonary nodules are located in the lung periphery, where conventional bronchoscopes face clear limitations in reaching deep-seated lesions. Compounding this, dynamic discrepancies between preoperative CT imaging and the patient’s actual respiratory state introduce widespread localization errors in clinical practice.

This is not an efficiency problem. It is a capability that has yet to be established. How to reliably access targets within complex pulmonary anatomy, and how to achieve precise localization in a dynamically shifting environment—these capabilities directly determine diagnostic accuracy and safety. They represent a textbook “capability-gap opportunity.”

For investors, such opportunities share distinct hallmarks: well-defined demand, clear pain points, and high technological barriers. Once a breakthrough is achieved, it typically produces durable competitive moats and extended growth cycles.

III. Noah Medical: A Strategic Entry Through the Capability Gap

As the industry migrates from “efficiency optimization” to “capability creation,” Noah Medical has chosen to enter precisely through the capability gap described above—targeting the core challenge of the confirmatory diagnosis stage in early lung cancer detection, and using technology to enhance lesion access and localization, completing a critical missing link in the diagnostic chain.

The technological foundation of this approach lies in the deep integration of real-time image-based localization, AI, and robotic control systems. The Galaxy system dynamically corrects discrepancies between imaging and the patient’s anatomy during the procedure, delivering higher-precision lesion localization in complex environments. This is the single most critical technical challenge in diagnosing peripheral lung nodules today.

Core Clinical Data

Since receiving FDA clearance in 2023, the Galaxy system has been used in over 10,000 clinical procedures across an installed base of more than 50 systems. Robotic navigational bronchoscopy diagnostic yield exceeds 90–93%, with a lesion localization success rate of approximately 96% and a low complication rate, demonstrating a strong safety profile. In the robotic bronchoscopy segment for pulmonary applications, Galaxy holds roughly 5% market share and remains in a phase of rapid growth.

From a market standpoint, the global natural orifice surgical robotics market is expected to surpass USD 80 billion, with the lung cancer biopsy sub-segment alone representing approximately USD 6 billion. China’s surgical robotics market is projected to sustain a 30–36% compound annual growth rate over the coming years, with select early-stage innovative sub-segments growing even faster. More critically, the shift toward non-invasive approaches is continuously expanding the addressable patient population—patients previously excluded due to procedural risk or diagnostic difficulty are steadily entering the diagnosable and treatable pool.

The core value of Noah Medical’s chosen path lies in combining assured demand with room for expansion: on one hand, lung cancer diagnosis and treatment represents a large and steadily growing base of inelastic clinical need; on the other, the precision access and localization capabilities built on the natural orifice approach carry platform potential for replication across other specialties.

Noah Medical is not positioned in a single-product niche. It sits along a capability pathway with the potential for progressive, multi-specialty expansion.

Conclusion

The investment logic of medical robotics ultimately comes down to a judgment about problem hierarchy. Amid similar levels of technological excitement and market narrative, the companies that choose to tackle clinical problems not yet effectively solved—and that create new medical capabilities through technology—are the ones most likely to deliver true long-term structural value.

Noah Medical is a representative company worthy of sustained attention within this framework. Subsequent articles in this series will further examine its technology pathway, clinical evidence, and commercialization trajectory.

— This is the first article in the Noah Medical deep-dive research series —

IRIS Optronics Leads the New Era of ChLCD e-Paper

By
Advertorial Desk
-

Touch Taiwan 2026 Showcases Full-Color e-Paper and Sustainable Display Future

TAIPEI, April 13, 2026 /PRNewswire/ — IRIS Optronics, a leader in full-color Cholesteric Liquid Crystal Display (ChLCD) e-Paper technology, took center stage at Touch Taiwan 2026 under the theme “New Era of ChLCD e-Paper.” The company showcased the latest achievements across the ChLCD e-Paper supply chain and partnered with domestic and international collaborators to present cutting-edge applications spanning outdoor transportation, smart city infrastructure, and indoor retail environments.

These solutions address the growing demand for sustainable technologies from consumers, enterprises, and government sectors. During the event, IRIS Optronics also unveiled its new ecosticker™ digital photo frame, hosted an international technology forum, and held an industry network inauguration ceremony—marking a key milestone in the transition from technological innovation to ecosystem-wide collaboration.

“IRIS Optronics continues to drive innovation with ChLCD e-Paper technology at its core. At this year’s Touch Taiwan, we partnered with industry leaders from Taiwan, Japan, Europe, USA, and mainland China to showcase the latest applications, attracting strong interest from sectors including healthcare, transportation, outdoor signage, and retail. With our core strengths—true full color, ultra-wide temperature range, and ultra-low power consumption—we are enabling industries to advance their sustainability goals,” said Dr. Albert Liao, Chairman & CEO of IRIS Optronics. “In addition to these business opportunities, we also unveiled a smart marketing human-machine interface integrating infrared palm vein recognition, and demonstrated our stacked bistable ChLCD technology, which increases reflectance from the industry standard of 30% to 50%.”

Strategic Partnerships Accelerate Commercial Deployment

In smart transportation, IRIS Optronics partnered with Askey Computer to deploy smart poles and smart bus stops, now implemented across multiple cities in Taiwan. The company also collaborated with system integrators Green Ideas Technology and GiantPlus to expand into parking meters and outdoor signage applications. In addition, panel manufacturer Solomon Goldentek Display co-exhibited a modular tiling display with IRIS Optronics, demonstrating a scalable pathway toward large-format displays using existing production lines.

In the healthcare sector, deployments at Taichung Veterans General Hospital and Taipei City Hospital demonstrated how e-Paper solutions can reduce staffing workloads and enhance real-time information accuracy. IRIS Optronics also introduced an e-Paper solution compatible with in-vehicle advertising, expanding into digital media applications for MRT and high-speed rail systems.

ecosticker™ Debut: Bringing True Full-Color e-Paper Indoors

At the exhibition, IRIS Optronics officially launched the ecosticker™ digital photo frame, extending its full-color ChLCD e-Paper technology from outdoor and public applications into indoor living spaces. This 10-inch device features extended battery duration, near-zero power consumption, and vivid full-color performance, delivering over 16 million colors—overcoming the limitations of conventional e-Paper. Weighing 955 grams and requiring no power outlet, the ecosticker™ can be easily installed in homes, galleries, and retail environments—simply hang it anywhere and visible anytime. The launch marks ChLCD e-Paper’s entry into indoor applications, offering a new solution for paperless displays and energy-efficient lifestyles.

International Forum Explores the Future of ChLCD

On the opening day, IRIS Optronics hosted the “New Era of ChLCD e-Paper Forum,” bringing together global experts from industry and academia to discuss emerging trends and opportunities.

Dr. Albert Liao opened the forum with a keynote titled “ChLCD Overturns The Display Application Landscape, Creating A New Blue Ocean Market,” highlighting how the technology is creating new market opportunities.

Speakers included:

  • Dr. Asad Khan, CEO of Kent Displays (USA), on “Evolution of Cholesteric Display Technologies and The Romance With Consumer Products”
  • Osamu Nakahashi, Chairman of CO-WIN (Japan), on “Silent Screens Transforming Stations, Cities, and Factories: The World Opened by Cholesteric e-Paper”
  • Associate Professor Kishi Takahiro, University of Tsukuba (Japan), on “From Visualization to Action: Revolutionizing Risk Delivery via Next-Gen Digital Interfaces”
  • George Chang, Director at Askey Computer, on “e-Paper Driving New Smart City Infrastructure — Cross-Domain Implementation by Askey Computer”

Industry Network Established to Strengthen the Ecosystem

Following the forum, IRIS Optronics hosted the “ChLCD Industry Network Dinner” bringing together hundred partners across materials, manufacturing, system integration, and application sectors.

The network aims to foster collaboration, accelerate global adoption of ChLCD e-Paper, and deliver sustainable, cost-effective display solutions.

[About IRIS Optronics]

Founded in 2012 in Tainan, Taiwan, IRIS Optronics develops proprietary full-color ChLCD e-Paper technology. The company delivers ultra-wide color gamut displays, advanced optoelectronic integration solutions, and modular large-format systems. Its applications span transportation, healthcare, retail, lifestyle, art, and education—helping cities and industries transition toward sustainable “green display” solutions. Guided by its core values—Integrity, Responsibility, Innovation, and Sharing—IRIS Optronics is building a global e-Paper ecosystem, empowering partners across materials, equipment, IC design, and system integration to drive both commercial success and ESG impact.

Heritage Spanish brand Osborne taps Singapore distributor Octopus to drive Asia-Pacific Growth

By
Advertorial Desk
-

  • Partnership opens pathway for joint product development and regional expansion
  • Osborne aligns interests by taking S$5m equity stake in Octopus
SINGAPORE – Media OutReach Newswire – 13 April 2026 – Spain-based Grupo Osborne (“Osborne”), one of Europe’s oldest producers of wines and spirits, has appointed Octopus (APAC) Holdings Limited (“Octopus” or “Company”) as its principal distributor in Singapore under a five-year mandate, alongside a S$5 million strategic equity investment, marking a step towards extending the Company’s business model beyond distribution into brand creation.
Founded in 1772, Osborne is an international food and beverage group with a portfolio of premium brands and a presence in over 70 countries, supported by production facilities across Spain. It owns and manages more than 30 brands across wines, spirits and gourmet products, including global labels such as Carlos I brandy, Nordés gin, Cinco Jotas ham and Bodegas Montecillo wines.
As part of the partnership, Osborne will invest S$5 million in Singapore-listed Octopus by subscribing for new shares at S$0.0680 each, representing a 13.33% premium to the Company’s last closing price of S$0.0600 on 9 April 2026. The investment will give Osborne a 6.40% equity stake, aligning its interests with Octopus’ regional growth strategy.

Osborne, a family-owned business now led by the sixth generation, in 2024 reported net sales of €251 million (S$372 million) and net profit of €16.1 million.

Under the five-year agreement, renewable for successive three-year periods, Octopus will manage Osborne’s distribution value chain in Singapore. This includes distribution across retail, on-trade and e-commerce channels, alongside marketing, trade execution and brand positioning.

From distribution to product development
Beyond distribution, the partnership opens a pathway for Octopus to develop its own wines and spirits by leveraging Osborne’s production expertise. Products developed under this collaboration will be tailored for Asian palates, drawing on Octopus’ on-the-ground understanding of consumer preferences, pricing dynamics and route-to-market execution.

Through its wholly owned Octopus Distribution Networks, established in 2011, the Company has built a regional wholesale platform specialising in the import, distribution and marketing of beverages across Southeast Asia. Its portfolio spans both local and international brands with established provenance and heritage, supplying a customer base ranging from high-end cocktail bars to mass-market retailers.
The Osborne partnership marks a natural extension of this model. It positions Octopus to move upstream from distributor to brand creator, with the ability to originate and scale products designed for regional markets. Economic benefits from jointly developed products will be shared equally between both parties.

Scalable platform for regional expansion
The partnership is structured as a scalable regional platform, enabling Octopus to extend Osborne’s distribution footprint across Asia-Pacific. Expansion beyond Singapore will be carried out via separate local distribution agreements with existing and newly acquired distribution companies. This allows the network to scale progressively as Octopus builds its regional presence.

Mr Fernando Terry Osborne, Chief Executive Officer of Osborne, said: “This partnership with Octopus represents a decisive step in Osborne’s international growth strategy. Asia-Pacific is a priority region for our brands, and Singapore provides a solid platform from which to strengthen our presence in high-potential markets. The investment in Octopus reflects our confidence in their operational capabilities and business vision. We share the same ambition: to bring the excellence and authenticity of our brands to new consumers across the region. We are convinced that, together, we can accelerate our expansion and develop value propositions adapted to the preferences of the Asian market.”

Mr Paul Hopkins, Chief Executive Officer of Octopus, said the collaboration expands the Company’s role within the value chain.

“This partnership goes beyond distribution. By combining Osborne’s production expertise with our market knowledge, we will be able to develop products built for Asian consumers from the outset,” he said. “It marks a step forward in our strategy to become not just a distributor of global brands, but a creator and owner of brands in our own right.”

The distribution agreement is expected to contribute to Octopus’ revenue growth and enhance margins through a greater mix of premium, brand-led products.

Octopus intends to replicate this model across future partnerships, combining distribution mandates and strategic investments, where appropriate, with product co-development to build a regional, brand-led platform.

Hashtag: #Octopus






The issuer is solely responsible for the content of this announcement.

Octopus (APAC) Holdings Limited

Octopus (APAC) Holdings Limited is a Singapore-listed alcohol distributor focused on building a scalable regional platform through acquisitions and partnerships with global brand owners. Formerly known as GS Holdings Limited, the Company distributes a portfolio of beers, wines and spirits across Asia-Pacific through a network spanning retail, on-trade and wholesale channels.

For more information:

Grupo Osborne

Founded in 1772, Grupo Osborne is one of the oldest and most established producers of wines and spirits in Europe, with a heritage spanning more than 250 years. The family-owned group has evolved into an internationally recognised food and beverage company with a diversified portfolio of premium brands and a presence in over 70 countries.

Grupo Osborne owns and manages more than 30 brands across wines, spirits and gourmet products, including globally recognised labels such as Carlos I brandy, Nordés gin and Bodegas Montecillo wines. Its products are supported by multiple production facilities in Spain and an expanding international footprint, underscoring its role as a global ambassador of Spanish gastronomy and premium beverages.
With a legacy built on heritage, craftsmanship and international expansion, Grupo Osborne is widely regarded as one of Spain’s most iconic consumer brands and among the oldest continuously operating companies in the global wine and spirits industry.

For more information: https://www.osborne.es/en

Ardingly College Vietnam (ACVN) Partners with Vietnam Prosperity Joint Stock Commercial Bank (VPBank) to Launch “World Ready” Financial-Education Solution

By
Advertorial Desk
-

HO CHI MINH CITY, Vietnam, April 13, 2026 /PRNewswire/ — Ardingly College Vietnam Joint Stock Company, in collaboration with Vietnam Prosperity Joint Stock Commercial Bank (VPBank), officially announces the launch of a Financial–Education solution named “World Ready,” exclusively designed for parents of students at Ardingly College Vietnam. This innovative financial solution aims to support families seeking international education for their children by enabling long-term financial planning with peace of mind, while preserving their initial capital for future educational stages beyond secondary school.

The first British boarding school and an ambition to become an international education hub in the Northwest.
The first British boarding school and an ambition to become an international education hub in the Northwest.

This marks the first time in Vietnam that a financial solution has been developed through a strategic partnership between a bank and an educational institution, offering a unique dual-benefit model for parents. Specifically, with an initial savings deposit (depending on the selected duration, programme, and study format), parents can enroll in the “World Ready” package, under which VPBank guarantees full payment of tuition fees and related expenses throughout the student’s study period at Ardingly College Vietnam, with no additional costs incurred. Upon completion of the contracted programme, parents will receive back 100% of their initial principal, along with any remaining accrued interest (if applicable, depending on chosen options).

A key advantage of the programme is the full protection of the initial investment at a reputable financial institution, while shielding parents from any annual tuition fee increases. This ensures complete confidence in long-term financial planning for their children’s education.

The “World Ready” Financial–Education package is also considered a practical, cost-efficient, and effective solution for corporations, including multinational companies operating in Vietnam, in designing educational benefit policies for their senior employees’ children—particularly amid ongoing global uncertainties in exchange rates, interest rates, and operational costs.

“World Ready,” the name of this integrated Financial–Education solution, is also the core slogan of Ardingly College Vietnam, reflecting its educational philosophy: preparing students to thrive in a dynamic and ever-changing world.

About Ardingly College Vietnam
Ardingly College Vietnam is an authentic British boarding school in Vietnam, developed through a partnership between Khoi Nguyen Investment Group (KNI) and Ardingly College UK—a prestigious British boarding school established in 1858. In the UK, Ardingly College ranks among the top 40 independent boarding schools and is recognized as a leading school for International Baccalaureate (IB) academic results.

Ardingly College Vietnam inherits a modern and well-equipped campus with a total investment of nearly VND 700 billion, formerly the Canada International School Lao Cai (CIS Lao Cai), developed by KNI and located in the administrative center of the former Lao Cai province. With strong infrastructure advantages, particularly its newly completed premium boarding facilities (as of October 2025), Ardingly College

Vietnam, as part of the global Ardingly College family, fully adopts the educational philosophy, operational model, quality standards, and distinctive British boarding system of Ardingly College UK.

Guided by the “World Ready” philosophy, Ardingly College Vietnam is committed to the holistic development of students in academics, skills, and character, preparing them for international higher education and to become global citizens in an ever-evolving world.

Academic Programmes

Ardingly College Vietnam currently offers two educational pathways, both available in day and boarding formats:

  • Bilingual Programme: Based on the Vietnamese Ministry of Education and Training (MOET) curriculum from Grade 1 to Grade 12, integrated with English as a Second Language (ESL) following Oxford international standards. The programme leads to the Vietnamese High School Diploma.
  • International Programme: Based on the OxfordAQA curriculum from Grade 6 to Grade 12/Sixth Form, leading to IGCSE and A-Level qualifications.

Both programmes accept boarding students from Grade 6 (age 11) to Grade 12 (age 18), regardless of nationality or gender. The school is currently recruiting for its inaugural academic year 2026–2027 and is offering only 100 “World Ready” Financial–Education packages for first-year students.

 

Ardingly College Vietnam Joint Stock Company, in collaboration with Vietnam Prosperity Joint Stock Commercial Bank (VPBank), announces the launch of a financial–education linked product named “World Ready.”
Ardingly College Vietnam Joint Stock Company, in collaboration with Vietnam Prosperity Joint Stock Commercial Bank (VPBank), announces the launch of a financial–education linked product named “World Ready.”

Lingnan University expands Business Case Competition to Greater Bay Area with record participation

By
Advertorial Desk
-

HONG KONG, April 13, 2026 /PRNewswire/ — To enhance the business acumen and practical experience of students from Hong Kong and Greater Bay Area (GBA) tertiary institutions, the Hong Kong Institute of Business Studies (HKIBS) at Lingnan University organised the third Business Case Competition (LUBCC) 2026. The Final Presentation Day and Award Presentation Ceremony were successfully held yesterday (12 April). This year’s competition expanded for the first time to include five GBA universities: Shenzhen University, Jinan University, Foshan University, Guangdong University of Finance and Economics, and Guangdong University of Technology. The first-prize teams were Lingnan University and Foshan University.

The Hong Kong Institute of Business Studies at Lingnan University organises the third Business Case Competition (LUBCC) 2026.
The Hong Kong Institute of Business Studies at Lingnan University organises the third Business Case Competition (LUBCC) 2026.

A total of 445 students from 98 teams registered for this year’s competition. This represents a significant 22.5 per cent increase in the number of participants compared with the previous year. The competition featured real-world business cases provided by various government departments and corporations, including the Hong Kong Police Force and MTR Corporation Limited, for participants to analyse collectively and devise optimal business strategies.

Prof Shi Shanshan, Associate Dean (TP Studies) of the Faculty of Business at Lingnan University, delivered a welcome address, noting that the inclusion of several GBA universities this year helped foster academic and cultural exchanges across institutions. She said “The number of participants this year reached a record high, reflecting the growing student demand for practical platforms that simulate the workplace. Participants are required to tackle real-world problems faced by different enterprises, gaining insights into diverse cultural and business contexts. They flexibly apply the theoretical knowledge learned in the classroom to solve business challenges with innovative solutions. Through cross-institutional competitions like this, the Faculty of Business aims to strengthen students’ cross-border market mindset, enhance their analytical and problem-solving skills, and nurture future leaders capable of addressing global business challenges.”

The business cases for this year’s competition were provided by government departments and corporations, spanning areas such as public services, transportation, property management, and healthcare. These included the Hong Kong Police Force, Integrated Property Management Platform of China Resources Longdation Company Limited, MTR Corporation Limited, and New Town Medical Group (listed in no particular order). A total of 20 teams from the Undergraduate Division, Taught Postgraduate Division, and GBA universities advanced to the final round. Each team was required to conduct an in-depth analysis of the real-life business challenge provided by the supporting organisations and their strategic recommendations tailored to address the issues identified. Outstanding proposals may be considered as reference strategies by the respective organisations. The final judging panel, comprising industry experts and academics, engaged with the teams through insightful questions and feedback.

The Hong Kong Police Force invited students to propose a targeted, multi-channel mission-based marketing and education campaign to solve low public awareness and sustained engagement across demographics for the HKPF Super App. Integrated Property Management Platform of China Resources Longdation Company Limited requested students to formulate new strategies to solve client confusion by clearly unifying the CRLIPM Platform’s brand and relationship structure across its three companies, and to enhance public engagement through its WeChat official account while making CRLIPM content trend on social media. The case topic for MTR Corporation Limited was developing a strategy and implementation plan to reduce fare evasion on MTR Light Rail. New Town Medical Group required students to provide a marketing and outreach strategy to raise public awareness of the CDCC scheme, attract eligible participants to pair with NTMG doctors, and retain enrolled participants for follow-up doctor, nurse clinic, and optometrist services—while promoting the role of nurse clinics in the co-care model. These real-world cases spanned diverse fields such as public services, property management, transportation, and healthcare, testing the students’ cross-industry business analysis capabilities and innovative thinking.

The event concluded with the much-anticipated Award Presentation Ceremony. Prizes were awarded to the top-performing teams in various categories, recognizing their exceptional analyses and innovative strategies.

For the full list of awardees, please refer to the table below:

Award

Team Name

Students Name

Case

First Prize-1

B-LU-1

Huang Guanzhe

Yu Yunwen

Zhong Zhiheng

Lyu Yichen

MTR Corporation Limited

First Prize-2

C-GBA-1

Liu Danyi

Shu Zhitong

Jiang Yonglin

Li Zhiyan

The Hong Kong Police Force

Second Prize-1

A-LU-4

Wang Xiaowen

W Chenying

Chen Yue

Huang Zixuan

Xue Lidan

China Resources Longdation Company Limited

Second Prize-2

A-LU-9

Jiang Di

Wang Gan

AYIZIBA Awuti

Liu Jie

Zhang Xiaoxuan

China Resources Longdation Company Limited

Second Prize-3

C-LU-5

Li Kun

Zhang Xiaoyu

Gao Jiaying

Chen Tongfei

Wu Jieyu

Hong Kong Police Force

Second Prize-4

A-LU-8

Su Siqi

Yang Jingyao

Xu Lu

Cui Zhuo Xin

China Resources Longdation Company Limited

Third Prize-1

C-GBA-7

Zhou Renhong

Feng Yuhan

Xiao Kailin

Wang Zhe

Yuan Yujie

The Hong Kong Police Force

Third Prize-2

D-GBA-8

Zhang Zhuoer

Xu Xinyi

Jiang Ao

Liao Zihan

Jiang Xinyue

New Town Medical Group

Third Prize-3

D-LU-4

Fan Ke Er

Ji Yi

Xu Yi Fan

He Yu Jie

New Town Medical Group

Third Prize-4

B-GBA-8

Li Yiping

Wu Liuchenchen

Stefanie Marie Yin Zhuo

Wang Yuefei

Qiu Jiayi

MTR Corporation Limited

Third Prize-5

C-GBA-3

Liang Qian

Liu Huiwen

Liu Qian

Tan Renqi

Cai Anlin

The Hong Kong Police Force

Third Prize-6

A-LU-2

Zhao Jingyan

Liu Xinyi

Yang Siya

Zhou Xingyu

Lu Yuhan

China Resources Longdation Company Limited

Best Presenter Award-1

A-LU-2

Lu Yuhan

China Resources Longdation Company Limited

Best Presenter Award-2

B-LU-1

Huang Guanzhe

MTR Corporation Limited

Most Popular Video Award (First Prize)

B-LU-8

Zhou Yifan

Yang Yuhan

Sun Yan

Wu Fangdi

He Yuchen

MTR Corporation Limited

Most Popular Video Award (Second Prize)-1

B-GBA-8

Li Yiping

Wu Liuchenchen

Stefanie Marie Yin Zhuo

Wang Yuefei

Qiu Jiayi

MTR Corporation Limited

Most Popular Video Award (Second Prize)-2

C-LU-2

Zhang Jianing

Li Shujie

Wang Ziheng

Wei Yi

Li Yuyi

The Hong Kong Police Force

Most Popular Video Award (Third Prize)-1

B-LU-1

Huang Guanzhe

Yu Yunwen

Zhong Zhiheng

Lyu Yichen

MTR Corporation Limited

Most Popular Video Award (Third Prize)-2

D-LU-3

Huang Chen Xi

Guo Ming Qi

Wang Jing Rui

Yu Zhen Yu

New Town Medical Group

Most Popular Video Award (Third Prize)-3

A-LU-2

Zhao Jingyan

Liu Xinyi

Yang Siya

Zhou Xingyu

Lu Yuhan

China Resources Longdation Company Limited

Merit Award-1

C-LU-2

Zhang Jianing

Li Shujie

Wang Ziheng

Wei Yi

Li Yuyi

The Hong Kong Police Force

Merit Award-2

B-GBA-2

Yang Ziyang

Li Xinyao

Ma Yuan

Lin Jiayu

MTR Corporation Limited

Merit Award-3

A-LU-7

Chen Jiawang

Luo Yaxi

Lin Qiuyi

Yu Jiangnan

Li Zihao

China Resources Longdation Company Limited

Merit Award-4

D-LU-9

Chen Junyi

Zhou Yixuan

Liang Lexi

KANEDA Rippei

He Ziyue

New Town Medical Group

Merit Award-5

B-LU-8

Zhou Yifan

Yang Yuhan

Sun Yan

Wu Fangdi

He Yuchen

MTR Corporation Limited

Merit Award-6

D-GBA-2

Hu Zhihao

Qiu Liqing

Wang Zhisheng

Huang Jiaming

Hong Kunpeng

New Town Medical Group

Merit Award-7

B-GBA-1

Lin Jiamei

Ye Rui

Deng Huinan

Dang Hanmei

MTR Corporation Limited

Merit Award-8

D-LU-3

Huang Chen Xi

Guo Ming Qi

Wang Jing Rui

Yu Zhen Yu

New Town Medical Group

 

1...686687688...6,607Page 687 of 6,607